» Articles » PMID: 11992002

RelB-p50 NF-kappa B Complexes Are Selectively Induced by Cytomegalovirus Immediate-early Protein 1: Differential Regulation of Bcl-x(L) Promoter Activity by NF-kappa B Family Members

Overview
Journal J Virol
Date 2002 May 7
PMID 11992002
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The NF-kappa B/Rel family has been implicated in control of transcription of the Bcl-x(L) gene, a target which mediates cell survival signals. The cytomegalovirus (CMV) immediate-early protein 1 (IE1) was previously shown to induce NF-kappa B activity. Here, we report that in both vascular smooth muscle cells (SMCs) and NIH 3T3 cells, surprisingly, IE1 failed to induce Bcl-x(L) promoter activity, although it induced activity of E8-CAT, a reporter construct driven by two copies of the NF-kappa B element upstream of the c-myc promoter (upstream regulatory element [URE]). Thus, the subunit nature of the NF-kappa B/Rel factors induced by IE1 was examined using immunofluorescence and immunoblotting. IE1 was found to selectively induce nuclear RelB and p50 in SMCs and NIH 3T3 cells. An increase in RelB protein mediated by IE1 could, in part, be related to an increase in steady-state relB mRNA levels. Consistent with this subunit identification, IE1 was unable to induce E8-CAT activity in relB(-/-) murine embryonic fibroblast cells. In cotransfection analysis of SMCs and NIH 3T3 cells, RelB and p50 proteins failed to induce Bcl-x(L) promoter activity while inducing E8-CAT. Furthermore, the NF-kappa B element of the Bcl-x(L) promoter only weakly bound RelB-p50 complexes compared to the URE NF-kappa B element. Overall, these findings demonstrate in SMCs and NIH 3T3 cells that the CMV IE1 protein selectively induces RelB and p50, which fail to activate the Bcl-x(L) promoter, indicating a strong specificity of binding and activity for the RelB member of the NF-kappa B family. Furthermore, our results implicate RelB in CMV infection of cells such as vascular SMCs.

Citing Articles

Atypical IκB Bcl3 enhances the generation of the NF-κB p52 homodimer.

Pan W, Deng L, Wang H, Wang V Front Cell Dev Biol. 2022; 10:930619.

PMID: 35990614 PMC: 9389042. DOI: 10.3389/fcell.2022.930619.


PPE38-Secretion-Dependent Proteins of Alter NF-kB Signalling and Inflammatory Responses in Macrophages.

Gallant J, Heunis T, Beltran C, Schildermans K, Bruijns S, Mertens I Front Immunol. 2021; 12:702359.

PMID: 34276695 PMC: 8284050. DOI: 10.3389/fimmu.2021.702359.


NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB.

Kabacaoglu D, Ruess D, Ai J, Algul H Cancers (Basel). 2019; 11(7).

PMID: 31277415 PMC: 6679104. DOI: 10.3390/cancers11070937.


The IκB Kinases Restrict Human Cytomegalovirus Infection.

Goodwin C, Munger J J Virol. 2019; 93(9).

PMID: 30760575 PMC: 6475784. DOI: 10.1128/JVI.02030-18.


Noncanonical NF-κB in Cancer.

Tegowski M, Baldwin A Biomedicines. 2018; 6(2).

PMID: 29874793 PMC: 6027307. DOI: 10.3390/biomedicines6020066.


References
1.
Arsura M, Wu M, Sonenshein G . TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity. 1996; 5(1):31-40. DOI: 10.1016/s1074-7613(00)80307-6. View

2.
Beldekas J, Gerstenfeld L, Sonenshein G, Franzblau C . Cell density and estradiol modulation of procollagen type III in cultured calf smooth muscle cells. J Biol Chem. 1982; 257(20):12252-6. View

3.
Everett R, Dunlop M . Trans activation of plasmid-borne promoters by adenovirus and several herpes group viruses. Nucleic Acids Res. 1984; 12(15):5969-78. PMC: 320050. DOI: 10.1093/nar/12.15.5969. View

4.
Everett R . Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J. 1984; 3(13):3135-41. PMC: 557829. DOI: 10.1002/j.1460-2075.1984.tb02270.x. View

5.
Cherrington J, Mocarski E . Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol. 1989; 63(3):1435-40. PMC: 247847. DOI: 10.1128/JVI.63.3.1435-1440.1989. View